[1]
Ankudavičius, V. 2018. UPDATED ALEX TRIAL RESULTS: ALECTINIB▼ – NEW STANDART IN TREATMENT ALK POSITIVE NONSMALL CELL LUNG CANCER. Pulmonology and allergology. 2, 2 (Sep. 2018), 152-155. DOI:https://doi.org/10.37499/PIA.172.